iHT² Health IT Summit Seattle 2013 - Josephine Briggs, MD, National Center for Complementary and Alternative Medicine National Institutes of Health - Opening Keynote "Research in an IT Connected World: Building Better Partnerships – NIH and Health Ca
Josephine Briggs, MD
Director
National Center for Complementary and Alternative Medicine
National Institutes of Health
Opening Keynote "Research in an IT Connected World: Building Better Partnerships – NIH and Health Care Systems"
The era of ‘Big Data’ has arrived for biomedical research, bringing with it immense challenges as well as spectacular opportunities. NIH is establishing major programs with the potential to transform the future of US biomedical research by building the capacities necessary for these challenges. These programs will strengthen research partnerships with health care systems and the IT networks that support them.
The Big Data to Knowledge (BD2K) initiative, to be launched in 2014, will implement a set of recommendations from the Data and Informatics Working Group to the Advisory Committee to the Director. Investments are planned to meet scientific needs to manage and utilize large complex datasets, including strengthening training, and investing in improved analysis methods and software development and dissemination. NIH is also evaluating strengthening data and software sharing policies, and the potential creation of catalogs of research data, and data/metadata standards.
The Common Fund’s Health Care Systems (HCS) Research Collaboratory program has the goal to strengthen the national capacity to implement cost-effective large-scale research studies by engaging major health care delivery organizations as research partners. The aim of the program is to provide a framework of implementation methods and best practices that will enable the participation of many health care systems in clinical research. Research conducted in partnership with health care systems is essential to strengthen the relevance of research results to health practice. Seven demonstration projects, currently in a feasibility phase, are developing detailed methods to implement rigorous randomized studies of questions of major public health impact. These studies, and the IT infrastructure that will make them possible, will be described in detail.
Mark Frisse gave an outstanding presentation at the Redwood Mednet 2013 Conference "Connecting California to Improve Patient Care in 2013"
http://www.redwoodmednet.org/projects/events/20130725/index.html
From Research to Practice - New Models for Data-sharing and Collaboration to ...Health Data Consortium
Watch the webinar here: http://encore.meetingbridge.com/MB005418/140528/
Webinar transcript: http://hdc.membershipsoftware.org/Files/webinars/HDC-PwC%20NIH%20&%20PCORI%20Webinar%20Transcript%205_28_14.pdf
Patient-Centered Outcomes Research Institute (PCORI) Executive Director Joe Selby, MD, MPH; National Institutes of Health (NIH) Director and PCORI Board of Governors member Francis Collins, MD, PhD; and NIH Associate Director for Data Science Philip Bourne, PhD discussed new and emerging trends in big data for health, including:
- How researchers, patients, clinicians, and others are forging new models for data-sharing.
- Leveraging the quantity, variety, and analytic potential of health-related data for research and practice.
- Addressing patients’ perspectives, needs, and concerns in creating new opportunities for innovation and translational science.
- Exciting initiatives such as PCORnet, the National Patient-Centered Clinical Research Network initiative that PCORI is now helping to develop, and related open data and technology efforts such - as the NIH Health Systems Collaboratory and Big Data to Knowledge (BD2K) initiative.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
Towards Digitally Enabled Genomic Medicine: the Patient of The FutureLarry Smarr
12.02.22
Invited Speaker
Hacking Life
TTI/Vanguard Conference
Title: Towards Digitally Enabled Genomic Medicine: the Patient of The Future
San Jose, CA
Artificial Intelligence and Machine Learning will have a profound effect in transforming healthcare and bridging the historical gap of information asymmetry between the healthcare ecosystem and people
An Integrated Framework for Telediagnosis and Prescriptions in Herbal MedicineEswar Publications
Herbal medicine has been an age long tradition for the treatment and curing of diseases globally. Previous studies
on telediagnostic and prescription of orthodox medicine have been examined using the application of modern technology device to improve health care services. In spite of this, there is yet an exhaustive study on the integration of technological framework for telediagnosis and prescription in herbal medicine. Therefore, this research focused on development of collaborative teleconsultation and telediagnosis in sharing of information on herbal medication for patients in remote areas to improve healthcare delivery. WAVA based collaborative
framework was designed for telediagnosis and prescription in herbal medicine, it has multimedia features for video conferencing, and ability to record, capture and replay consultations with the capacity for edit, data compression and short messages (sms) between the teleconsultants. The framework study the propagation time, link media delay, packet loss, processing delay between all (tele-herbal consultant 1, 2, 3…n) connected to the system. Each herbal tele-consultant was aloted with peer IP address in order to join the telediagnosis video conference from their remote areas. The framework displays paradigms for data acquisition on herbal
medications, video-recording, and imagery of patients. The integration of this collaborative framework enhanced
telediagnosis of patients with better prescriptions on effective herbal drugs for speedy recovery.
Mark Frisse gave an outstanding presentation at the Redwood Mednet 2013 Conference "Connecting California to Improve Patient Care in 2013"
http://www.redwoodmednet.org/projects/events/20130725/index.html
From Research to Practice - New Models for Data-sharing and Collaboration to ...Health Data Consortium
Watch the webinar here: http://encore.meetingbridge.com/MB005418/140528/
Webinar transcript: http://hdc.membershipsoftware.org/Files/webinars/HDC-PwC%20NIH%20&%20PCORI%20Webinar%20Transcript%205_28_14.pdf
Patient-Centered Outcomes Research Institute (PCORI) Executive Director Joe Selby, MD, MPH; National Institutes of Health (NIH) Director and PCORI Board of Governors member Francis Collins, MD, PhD; and NIH Associate Director for Data Science Philip Bourne, PhD discussed new and emerging trends in big data for health, including:
- How researchers, patients, clinicians, and others are forging new models for data-sharing.
- Leveraging the quantity, variety, and analytic potential of health-related data for research and practice.
- Addressing patients’ perspectives, needs, and concerns in creating new opportunities for innovation and translational science.
- Exciting initiatives such as PCORnet, the National Patient-Centered Clinical Research Network initiative that PCORI is now helping to develop, and related open data and technology efforts such - as the NIH Health Systems Collaboratory and Big Data to Knowledge (BD2K) initiative.
Discover more health data resources on our website at http://www.healthdataconsortium.org/
Towards Digitally Enabled Genomic Medicine: the Patient of The FutureLarry Smarr
12.02.22
Invited Speaker
Hacking Life
TTI/Vanguard Conference
Title: Towards Digitally Enabled Genomic Medicine: the Patient of The Future
San Jose, CA
Artificial Intelligence and Machine Learning will have a profound effect in transforming healthcare and bridging the historical gap of information asymmetry between the healthcare ecosystem and people
An Integrated Framework for Telediagnosis and Prescriptions in Herbal MedicineEswar Publications
Herbal medicine has been an age long tradition for the treatment and curing of diseases globally. Previous studies
on telediagnostic and prescription of orthodox medicine have been examined using the application of modern technology device to improve health care services. In spite of this, there is yet an exhaustive study on the integration of technological framework for telediagnosis and prescription in herbal medicine. Therefore, this research focused on development of collaborative teleconsultation and telediagnosis in sharing of information on herbal medication for patients in remote areas to improve healthcare delivery. WAVA based collaborative
framework was designed for telediagnosis and prescription in herbal medicine, it has multimedia features for video conferencing, and ability to record, capture and replay consultations with the capacity for edit, data compression and short messages (sms) between the teleconsultants. The framework study the propagation time, link media delay, packet loss, processing delay between all (tele-herbal consultant 1, 2, 3…n) connected to the system. Each herbal tele-consultant was aloted with peer IP address in order to join the telediagnosis video conference from their remote areas. The framework displays paradigms for data acquisition on herbal
medications, video-recording, and imagery of patients. The integration of this collaborative framework enhanced
telediagnosis of patients with better prescriptions on effective herbal drugs for speedy recovery.
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
Health IT Summit in Chicago 2014 – “The EHR & Quality: The Current Evidence” with Abha Agrawal, MD, FACP, COO & VP of Medical Affairs, Norwegian American Hospital
Abha Agrawal, MD, FACP
COO & VP of Medical Affairs
Norwegian American Hospital
iHT2 case studies and presentations illustrate challenges, successes and various factors in the outcomes of numerous types of health IT implementations. They are interactive and dynamic sessions providing opportunity for dialogue, debate and exchanging ideas and best practices. This session will be presented by a thought leader in the provider, payer or government space.
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
Electronic cigarettes for smoking cessation: What's the evidence?Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of electronic cigarettes for smoking cessation.
Muhannad Malas and Robert Schwartz led the session and presented findings from their recent review:
Malas M, van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. (2016). Electronic cigarettes for smoking cessation: A systematic review. Nicotine & Tobacco Research, 18(10), 1926-1936.
http://healthevidence.org/view-article.aspx?a=electronic-cigarettes-smoking-cessation-systematic-review-29830
Cigarette smoking is among the top causes of preventable death and disease. Electronic cigarettes have been increasing in popularity among smokers who report using them for quitting or reducing smoking. This review examines the effectiveness of electronic cigarettes as cessation aids. Sixty two articles, including RCTs, experimental, longitudinal and cross sectional studies are included in this review. Findings suggest there is inconclusive evidence due to low quality of research. This webinar provides a comprehensive overview of current literature examining the effectiveness of electronic cigarettes for smoking cessation.
Since time has changed, the rectification, upgrading and innovation through disruptive ways have become a part of every aspect of our lives. From automobiles to communication every other line of lifestyle has seen an upgrade and so does the medicine
iHT2 Health IT Summit Atlanta 2013, Michael Matthews, Chief Executive Officer, MedVirginia, Central & Eastern Virginia's Regional Health Information Exchange , Case Study “Health Information Exchange: State and National Updates”
"Health Information Exchange in Oregon – Where We Are & Where We Are Going"
Moderator: Eric McLaughlin, Project Manager, Cognosante
Abigail Sears, Chief Executive Officer, OCHIN
Sharon Wentz, RN, Business Development Coordinator, CareAccord
Laurie Miller, RHIT, CCS-P, HISP Administrator, Gorge Health Connect
Paula Weldon, Project Manager, Jefferson Health Information Exchange
Using real-world evidence to investigate clinical research questionsKarin Verspoor
Adoption of electronic health records to document extensive clinical information brings with it the opportunity to utilise that information to support clinical research, and ultimately to support clinical decision making. In this talk, I discuss both these opportunities and the challenges that we face when working with real-world clinical data, and introduce some of the strategies that we are adopting to make this data more usable, and to extract more value from it. I specifically discuss the use of natural language processing to transform clinical documentation into structured data for this purpose.
Health IT Summit in Chicago 2014 – “The EHR & Quality: The Current Evidence” with Abha Agrawal, MD, FACP, COO & VP of Medical Affairs, Norwegian American Hospital
Abha Agrawal, MD, FACP
COO & VP of Medical Affairs
Norwegian American Hospital
iHT2 case studies and presentations illustrate challenges, successes and various factors in the outcomes of numerous types of health IT implementations. They are interactive and dynamic sessions providing opportunity for dialogue, debate and exchanging ideas and best practices. This session will be presented by a thought leader in the provider, payer or government space.
Disease Network is the science that has emerged to diagnose a disease from a network aspect
specifically. Networks are the group that interconnect to each others similarly disease networks are
the one that reveal concelled connection among apparently independent biomedical entities like
physiologic process, signaling receptors, in addition to genetic code, also they prove to exists
intitutive in addition to powerful way to learn/discover or diagnose a disease.Due to these networks,
we can now consume the elderly drugs and its method to learn/discover the new drug
accordingly.Example- Colchicine is used in gout but after repurposing it is also used in mediterranean
fever. This is because there are many factors that affect the body during mediterranean fever and
gout, we know that gout is a form of arthritis that causes pain in joints also mediterranean fever is the
one which is accompanied by pain in joints, therefore colchicine is used as a repurposed drug again.In
repurposing of medicines or drugs we first analyse the change in symptoms and identify the target
organ and accorgingly we produce a drug that is compatible with pharmacokinetics of the body. As
the availablity of transcriptomic,proteomic and metabolomic data sources are increasing day by day it helps in classification of disease .Also there are some networks reffered to as complex networks which can be called as collection of linked junctions/ nodes
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
Electronic cigarettes for smoking cessation: What's the evidence?Health Evidence™
Health Evidence hosted a 90 minute webinar examining the effectiveness of electronic cigarettes for smoking cessation.
Muhannad Malas and Robert Schwartz led the session and presented findings from their recent review:
Malas M, van der Tempel J, Schwartz R, Minichiello A, Lightfoot C, Noormohamed A, et al. (2016). Electronic cigarettes for smoking cessation: A systematic review. Nicotine & Tobacco Research, 18(10), 1926-1936.
http://healthevidence.org/view-article.aspx?a=electronic-cigarettes-smoking-cessation-systematic-review-29830
Cigarette smoking is among the top causes of preventable death and disease. Electronic cigarettes have been increasing in popularity among smokers who report using them for quitting or reducing smoking. This review examines the effectiveness of electronic cigarettes as cessation aids. Sixty two articles, including RCTs, experimental, longitudinal and cross sectional studies are included in this review. Findings suggest there is inconclusive evidence due to low quality of research. This webinar provides a comprehensive overview of current literature examining the effectiveness of electronic cigarettes for smoking cessation.
Since time has changed, the rectification, upgrading and innovation through disruptive ways have become a part of every aspect of our lives. From automobiles to communication every other line of lifestyle has seen an upgrade and so does the medicine
iHT2 Health IT Summit Atlanta 2013, Michael Matthews, Chief Executive Officer, MedVirginia, Central & Eastern Virginia's Regional Health Information Exchange , Case Study “Health Information Exchange: State and National Updates”
"Health Information Exchange in Oregon – Where We Are & Where We Are Going"
Moderator: Eric McLaughlin, Project Manager, Cognosante
Abigail Sears, Chief Executive Officer, OCHIN
Sharon Wentz, RN, Business Development Coordinator, CareAccord
Laurie Miller, RHIT, CCS-P, HISP Administrator, Gorge Health Connect
Paula Weldon, Project Manager, Jefferson Health Information Exchange
Dr. Sean Rogers
Medical Director
Bend Memorial Clinic
Case Study "Using Health IT for PCMH, Accountable Care and Population Health"
Learning obectives:
∙ Discuss how Bend Memorial transitioned to the patient-centered medical home delivery model
∙ Understand the key healthcare IT solutions toward population health management
∙ Identify key technologies and registries for patient outreach and patient engagement
∙ Discuss the quality and outcomes achieved for Bend Memorial (reduced admissions, reduced ED visits, and enhanced chronic care management)
Similar to iHT² Health IT Summit Seattle 2013 - Josephine Briggs, MD, National Center for Complementary and Alternative Medicine National Institutes of Health - Opening Keynote "Research in an IT Connected World: Building Better Partnerships – NIH and Health Ca
Improving health care outcomes with responsible data scienceWessel Kraaij
Keynote presentation by Wessel Kraaij at the Dutch pattern recognition and impage processing society (NVPBV) 29/5/2018, Eindhoven.
This talk discusses
1. trends in health care and respondible data science and their intersection
2. Secure federated analytics on distributed data repositories
3. Generating clinically relevant hypotheses from patient forum discussions.
The convergence of separate health systems has led to
a great increase in data, which some organisations are
struggling to get to grips with. Harnessing analytic tools
and sharing knowledge is the best way forward
The slide presentation that preceded of the annual Health Datapalooza in Washington DC, PCORI was pleased to participate in the latest installment in the Health Data Consortium and PricewaterhouseCoopers (PwC) Innovators in Health Data Series, a webinar featuring PCORI Executive Director Joe Selby, MD, MPH; NIH Director and PCORI Board of Governors member Francis Collins, MD, PhD; and Philip Bourne, PhD, NIH’s Associate Director for Data Science.
The Randomized Controlled Trial: The Gold Standard of Clinical Science and a ...marcus evans Network
Tim Fayram, St. Jude Medical Inc. - Speaker at the marcus evans Medical Device R&D Summit Fall 2013, held in Palm Beach, FL delivered his presentation entitled The Randomized Controlled Trial: The Gold Standard of Clinical Science and a Barrier to Innovation?
Clinical trial data wants to be free: Lessons from the ImmPort Immunology Dat...Barry Smith
Presentation to the Clinical and Research Ethics Seminar, Clinical and Translational Science Center, Buffalo, January 21, 2014
https://immport.niaid.nih.gov/
http://youtu.be/booqxkpvJMg
The Learning Health System: Thinking and Acting Across ScalesPhilip Payne
A Learning Health System (LHS) can be defined as an environment in which knowledge generation processes are embedded into daily clinical practice in order to continually improve the quality, safety, and outcomes of healthcare delivery. While still largely an aspirational goal, the promise of the LHS is a future in which every patient encounter is an opportunity to learn and improve that patient’s care, as well as the care their family and broader community receives. The foundation for building such an LHS can and should be the Electronic Health Record (EHR), which provides the basis for the comprehensive instrumentation and measurement of clinical phenotypes, as well as a means of delivering new evidence at the patient- and population levels. In this presentation, we will explore the ways in which such EHR-derived phenotypes can be combined with complementary data across a spectrum from biomolecules to population level trends, to both generate insights and deliver such knowledge in the right time, place, and format, ultimately improving clinical outcomes and value.
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
Technology is slowly but surely penetrating the healthcare industry in general and the clinical trials sector in particular. New and advanced solutions offer a variety of possibilities aimed to both improving existing processes and creating new and more efficient ones. And on top of all stands the desire to make clinical trials more patient centric.
In all of this, even though some of the technologies have yet to mature enough to meet the high quality standards necessary, it is important to know them and begin imagining the promise they hold for clinical trials.
Clinical data science is a rapidly evolving field that utilizes advanced analytics and machine learning techniques to extract meaningful insights from large scale healthcare data. In recent years, there has been a significant increase in the availability of electronic health records, genomic data, wearable devices, and other digital health technologies, generating vast amounts of data. This article presents a comprehensive review of the current state of clinical data science and its future prospects. The review begins by providing an overview of the foundational concepts and methodologies employed in clinical data science. It explores various data sources, including structured and unstructured data, and highlights the challenges associated with data quality, privacy, and interoperability. The role of artificial intelligence and machine learning algorithms in data analysis and prediction is examined, along with the importance of data preprocessing and feature selection techniques. G. Dileepkumar | Nimisha Prajapati | Simhavalli Godavarthi "Clinical Data Science and its Future" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-7 | Issue-3 , June 2023, URL: https://www.ijtsrd.com.com/papers/ijtsrd58588.pdf Paper URL: https://www.ijtsrd.com.com/pharmacy/pharmacy-practice/58588/clinical-data-science-and-its-future/g-dileepkumar
From personal health data to a personalized adviceWessel Kraaij
Invited talk at the health track of ICT.OPEN 2018, 20-3-2018
1. Related Data science challenges to Digital Health trends
2. Designing an infrastructure to support secure learning from distributed health data repositories, for personalized health advice
3. Supporting patients with rare diseases with patient driven research and the generation of new hypotheses based on patient experiences.
Similar to iHT² Health IT Summit Seattle 2013 - Josephine Briggs, MD, National Center for Complementary and Alternative Medicine National Institutes of Health - Opening Keynote "Research in an IT Connected World: Building Better Partnerships – NIH and Health Ca (20)
Development and implementation of a system to support prediction of suicide risk in the Department of Veterans Affairs - DR. Robert Bossarte and Paul Bradley
Instructions for Submissions thorugh G- Classroom.pptxJheel Barad
This presentation provides a briefing on how to upload submissions and documents in Google Classroom. It was prepared as part of an orientation for new Sainik School in-service teacher trainees. As a training officer, my goal is to ensure that you are comfortable and proficient with this essential tool for managing assignments and fostering student engagement.
Introduction to AI for Nonprofits with Tapp NetworkTechSoup
Dive into the world of AI! Experts Jon Hill and Tareq Monaur will guide you through AI's role in enhancing nonprofit websites and basic marketing strategies, making it easy to understand and apply.
Palestine last event orientationfvgnh .pptxRaedMohamed3
An EFL lesson about the current events in Palestine. It is intended to be for intermediate students who wish to increase their listening skills through a short lesson in power point.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
Biological screening of herbal drugs: Introduction and Need for
Phyto-Pharmacological Screening, New Strategies for evaluating
Natural Products, In vitro evaluation techniques for Antioxidants, Antimicrobial and Anticancer drugs. In vivo evaluation techniques
for Anti-inflammatory, Antiulcer, Anticancer, Wound healing, Antidiabetic, Hepatoprotective, Cardio protective, Diuretics and
Antifertility, Toxicity studies as per OECD guidelines
Embracing GenAI - A Strategic ImperativePeter Windle
Artificial Intelligence (AI) technologies such as Generative AI, Image Generators and Large Language Models have had a dramatic impact on teaching, learning and assessment over the past 18 months. The most immediate threat AI posed was to Academic Integrity with Higher Education Institutes (HEIs) focusing their efforts on combating the use of GenAI in assessment. Guidelines were developed for staff and students, policies put in place too. Innovative educators have forged paths in the use of Generative AI for teaching, learning and assessments leading to pockets of transformation springing up across HEIs, often with little or no top-down guidance, support or direction.
This Gasta posits a strategic approach to integrating AI into HEIs to prepare staff, students and the curriculum for an evolving world and workplace. We will highlight the advantages of working with these technologies beyond the realm of teaching, learning and assessment by considering prompt engineering skills, industry impact, curriculum changes, and the need for staff upskilling. In contrast, not engaging strategically with Generative AI poses risks, including falling behind peers, missed opportunities and failing to ensure our graduates remain employable. The rapid evolution of AI technologies necessitates a proactive and strategic approach if we are to remain relevant.
Operation “Blue Star” is the only event in the history of Independent India where the state went into war with its own people. Even after about 40 years it is not clear if it was culmination of states anger over people of the region, a political game of power or start of dictatorial chapter in the democratic setup.
The people of Punjab felt alienated from main stream due to denial of their just demands during a long democratic struggle since independence. As it happen all over the word, it led to militant struggle with great loss of lives of military, police and civilian personnel. Killing of Indira Gandhi and massacre of innocent Sikhs in Delhi and other India cities was also associated with this movement.
The French Revolution, which began in 1789, was a period of radical social and political upheaval in France. It marked the decline of absolute monarchies, the rise of secular and democratic republics, and the eventual rise of Napoleon Bonaparte. This revolutionary period is crucial in understanding the transition from feudalism to modernity in Europe.
For more information, visit-www.vavaclasses.com
Synthetic Fiber Construction in lab .pptxPavel ( NSTU)
Synthetic fiber production is a fascinating and complex field that blends chemistry, engineering, and environmental science. By understanding these aspects, students can gain a comprehensive view of synthetic fiber production, its impact on society and the environment, and the potential for future innovations. Synthetic fibers play a crucial role in modern society, impacting various aspects of daily life, industry, and the environment. ynthetic fibers are integral to modern life, offering a range of benefits from cost-effectiveness and versatility to innovative applications and performance characteristics. While they pose environmental challenges, ongoing research and development aim to create more sustainable and eco-friendly alternatives. Understanding the importance of synthetic fibers helps in appreciating their role in the economy, industry, and daily life, while also emphasizing the need for sustainable practices and innovation.
iHT² Health IT Summit Seattle 2013 - Josephine Briggs, MD, National Center for Complementary and Alternative Medicine National Institutes of Health - Opening Keynote "Research in an IT Connected World: Building Better Partnerships – NIH and Health Ca
1. Research in an IT
Connected World:
Building Better
Partnerships – NIH and
Health Care Systems
August 21, 2013
2. Building Partnerships
1. Why? The urgent need
2. Concrete examples of partnerships – the Health Care
System Collaboratory Demonstration Projects
3. Preliminary thoughts about IT capacities, methods,
rules
5. IOM: The Imperative for Action
Drivers of the Problem
Scientific uncertainty
Perverse economic and practice incentives
System fragmentation
Opacity as to cost, quality and outcomes
Lack of patient involvement
Underinvestment in population health
Clinical evidence development is not
keeping pace with the emergence of
new diagnostics, treatments and insights
into individual variation.
IOM- Learning Health Care System
8. Reversals
Examples:
Mortality was higher with recommended glycemic targets as
opposed to more permissive standards (ACCORD, NEJM
2008)
Routine use of pulmonary artery catheters worsened ICU
outcomes (NEJM, 2009)
Breast cancer survival was not improved by autologous stem
cell transplant and intensified chemo compared with
standard chemo (Tallman et al NEJM 2005)
Impermeable bedcovers have no benefit for adults with
asthma, in spite reduced dust mite exposure (Woodcock,
2003 NEJM
9. Take home lesson:
We don’t always know what we think we know.
(hence the need to continue to examine standards
of care)
10. What is a Practical Trial?
Defined Practical (pragmatic) Trials as those in which “the
hypothesis and study design are developed specifically to
answer the questions faced by decision makers”
Decision makers include patients, clinicians, payers,
& health care system policy makers
11. Pragmatic vs. Explanatory
Broad eligibility
Flexible interventions
Typical practitioners
No follow-up visits
Objective clinical outcome
Usual compliance
Intent-to-treat
Narrow eligibility
Strict instructions
Expert practitioners
Frequent follow-up visits
Surrogate outcomes
Close monitoring
ITT plus per protocol
Thorpe KE et al. J Clin Epidemiol 2009;62:464-75
12. What is a Pragmatic/Practical Trial?
The PRECIS Tool is Developed
Thorpe KE et al. CMAJ 2009;180:E47
13. Pragmatic Study Elements
Broad eligibility criteria
Flexible interventions
Typical practitioners
No follow-up visits
Clinical outcomes
Usual compliance
Intent-to-treat
Thorpe KE et al. CMAJ 2009;180:E47
14. The Urgent Need
We need continual improvement in standards of care
To achieve that we need pragmatic trials
We cannot maintain an artificial distinction between
research and quality improvement
15. Building a Partnership
1. Why? The urgent need
2. Concrete examples of partnerships –
the Health Care System Collaboratory
Demonstration Projects
3. Preliminary thoughts about IT capacities, methods, rules
16. The overall goal of the Commons Fund’s
Health Care System (HCS) Collaboratory is to
strengthen the national capacity to
implement cost-effective large-scale research
studies that engage health care delivery
organizations as research partners.
18. “The implications of this study are highly important. The lack of effectiveness of
active detection and isolation should prompt hospitals to discontinue the
practice for control of endemic MRSA in ICUs….”
19. Pragmatic Trial Demonstration Projects
1. Preventing hospital acquired infections: (PI Huang) Do intensified
antibacterial bathing measures reduce hospital-acquired infections?
Cluster randomized trial - HCA randomizing 50 hospitals – 375,000
patients.
2. Colorectal cancer screening: (PI Coronado) Does a simple intervention
implemented through Federally Qualified Health Centers improve colorectal
cancer screening? Cluster randomized trial 18 OCHIN Clinics – 10,000
patients.
3. Suicide prevention: (PI Simon) A pragmatic trial comparing suicide
prevention programs. Can patients who admit to suicidal thoughts in a
health care encounter be successfully randomized to one of two
management strategies and do interventions reduce subsequent suicide
attempts? Group Health, Kaiser Colorado – 16,000 patients.
20. Pragmatic Trial Demonstration Projects
4. Lumbar Spine imaging: (PI Jarvik) Does insertion of epidemiological
information into imaging reports reduce subsequent diagnostic and
therapeutic interventions? Kaiser, N Ca; Group Health, Mayo, Henry
Ford. Cluster randomized 128 clinics,135,000 imaging reports.
5. Nocturnal blood pressure control: (PI Rosenthal) Does taking anti-
hypertensive medications at night reduce CV events? U of Iowa and Duke
primary care clinics, 6,000 patients.
6. Collaborative care pain management model: (PI Debar) Study impact of
integration of psycho-social supports for patients with chronic pain on pain
measures and opioid use. 3 Kaiser regions, Georgia, Hawaii, Northwest.
Cluster randomized by practice. Several hundred practices, 6,000
patients.
7. Longer dialysis duration: (PI Dember) Does increasing dialysis duration
reduce mortality? Partners Fresenius, da Vita, Cluster randomized trial
of 402 dialysis units. 7000 patients.
21. Test and Strengthen Models for Clinical
Research in Partnership with Health Care
Delivery Systems
Develop capacity to leverage resources of major
integrated health care systems for large scale clinical
research studies
Test and improve methods to extract research quality
data from electronic health information systems
Strengthen relevance and translatability of research
results to ‘real world’ health practice
Develop and test more cost-effective models for large
scale randomized clinical trials
22. Building a Partnership
1. Why? The urgent need
2. Concrete examples of partnerships – the Health Care
System Collaboratory Demonstration Projects
3. Preliminary thoughts about Health IT
capacities, methods, rules to facilitate a
learning health care system
25. Data Steward #1
Authorized user
NIH DRN Secure Network
Portal
1
52
Data
tables
Review &
Run Query
3
Review &
Return
Results
4
6
Data
tables
Review &
Run Query
3
Review &
Return
Results
4
1- User creates and
submits query
(a computer program)
2- Data partners
retrieve query
3- Data partners
review and run query
against their local data
4- Data partners
review results
5- Data partners
return results via
secure network
6 Results are
aggregated
Data Steward #2
ONC
Query Health Compliant
27. The Goal of the IT Approach
Creating secure networking capabilities and
analysis tools
Build networking capacity, not a network
Insure that access to data occurs only with
data stewards’ permission and active
engagement
28. Leverages existing networks’ data and analysis tools
Can use many data types, e.g., EHR, claims, registries
Can use many data models, e.g., Mini-Sentinel, i2b2,
OMOP
Can use existing querying tools, e.g., Mini-Sentinel modular
programs
Every use requires the agreement of the data steward
Health
Plan 1
Health
Plan 2
CTSA 1
Research
Dataset 1
NIH Distributed Research Network Secure
Portal
Research
Dataset 2
CTSA 2 Registry
29. NIH DRN Secure Portal
Mini-Sentinel
Site A
Registry 1
Mini-Sentinel
Site B
Medical
Practice 1
PBRN 1
CTSA 1
Hospital
1
Research
dataset 1
NIH Distributed Research Network Coordinating Center
CTSA 2
Health
Plan 2
Health
Plan 1
Network
Managemen
t
Research
Support
Query
Support
Query Tool
Developmen
t
Knowledge
Database
Software
Developmen
t
Project
Managemen
t
Data Models
& Standards
Consultation
Health System
Expertise
Knowledge Management System
Cross project lessons learned, query tracking, meta-data capture, search functions, etc
AdministrationQuery Tools
SAS, SQL,
menu-drivenModular Programs
Summary Tables
Project 1
PROJECTS
LIRE study
Analytic ToolsFeasibility study
Query Interface Reporting Tools
Security Access Control
File Query Repository
User Administration
Workflow Management
30. Thorny issues
Defining the right questions
Ethical issues surrounding research on standards of
care: eg. when is waiver of consent appropriate
Optimum trial design for group or cluster randomized
trials
Preserving effective public-private partnerships
https://www.nihcollaboratory.org/
32. Pragmatic Trials
Pragmatic trials should test an intervention, or compare
several interventions.
The question should be important – to patients, payers
and with health care delivery systems.
The intervention should be reasonable simple and not
require a complex structure for implementation. System
level interventions may be particularly suitable.
The trial design should incorporate rigorous controls,
prospectively identified, preferable by randomization.
The monitoring and outcome assessment should be as
simple as possible – and potentially utilize electronic
health records.
Editor's Notes
Headline Figure 1
Within biomedical research, many data types Victims of our own success Data production outstrips data handling and analysis Major long-term changes are needed
Long associated with fields like particle physics, astronomy, and climatology New for biomedical research
The NIH DRN is a distributed data network. Each data steward (e.g., a hospital, practice, or health plan) maintains physical and operational control over its data. Queries are computer programs that can run without modification on data files that each data steward has transformed into an agreed format. A library of modular programs simplifies creation of frequently asked kinds of questions, e.g., “Among people with condition 1 who are new users of drug A, how many experience outcome X?” The software is compliant with ONC’s Query Health standards.
contact: jeff_brown@hphc.org
More detail about the functions of the coordinating center and the capabilities of the portal. Note there are a variety of projects. Project 1 represents any multi-center project that uses the DRN. “ LIRE” is a one-off sub-network built for the University of Washington pragmatic trial – the investigators have full control of it. No other user of the DRN sees it exists or can send queries to it. The investigators can choose to authorize specific other users if they wish to. “ Feasibility” is a reminder that the network can quickly do prep-to-research queries describing burden of illness, number of potential study participants, etc.